FutuRx
Marie Lindner, MD worked in executive roles in the pharmaceutical, biotech, venture capital, start-up, and Medtech companies with experience across therapeutic areas and modalities and between business and clinical development over 30 years. She was most recently recruited to start a team at Novartis Pharmaceuticals, focused on finding new trends in science and medicine. Dr. Lindner now retired, maintains several consultancies/boards.
Before Novartis, Marie led gastroenterology licensing at the Shire, after five years as a Venture Partner at BioAdvance, a startup biotech VC group, serving on 8 startup boards. Previously she worked in business/clinical development at five other medium/large biotech/pharma companies and co-founded two startups.
Dr. Lindner was board certified in internal medicine and clinical nutrition, did a general surgery residency and fellowship in atherosclerosis/lipid metabolism. She was a faculty member at the Hospital of the University of Pennsylvania and Children’s Hospital of Philadelphia.
This person is not in the org chart
This person is not in any offices
FutuRx
FutuRx is a biotech incubator founded by three leading global healthcare players. FutuRx leverages its access to the Israeli biotech industry, and to leading research institutes in Israel and worldwide, to identify and develop highly innovative technologies. Experts at Takeda, J&J, and OrbiMed are deeply involved in the project selection process and during the incubator period of each company. The result is a clear impact on the efficient translation of innovative research to clinically meaningful products.